Clinical Trial Update: Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating carvedilol to prevent chemotherapy-induced cardiotoxicity in patients with breast cancer and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Cardiotoxicity
• Heart Failure

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

Sponsor: University of Sao Paulo | Conditions: Breast Cancer, Heart Failure | Phase 3 | Status: COMPLETED